Feature | Coronavirus (COVID-19) | March 21, 2022 | By Melinda Taschetta-Millane
Attendance was healthy at the recent HIMSS22 in Orlando. Mask mandates had lifted just days before the event, but many attendees still elected to keep that extra layer of protection.

Attendance was healthy at the recent HIMSS22 in Orlando. Mask mandates had lifted just days before the event, but many attendees still elected to keep that extra layer of protection.

I recently came across a very interesting survey conducted by KFF Polling regarding the consequences of both ending—and keeping—COVID-19 restrictions. In late-February, federal, state and local authorities made the decision to ease pandemic restrictions, and though the majority of people are looking forward to easing back into normal life, most still are hesitant about potential lurking consequences of loosening the boundaries.

Are we at a turning point in this pandemic? The survey, The February KFF COVID-19 Vaccine Monitor, looks at what a return to normal means for most people. Overall, people feel the worst is over. According to the survey, six in ten adults (62%) say that when it comes to COVID-19 in the U.S., “the worst is behind us.” Another 17% say the worst is still yet to come, while 17% said they don’t think COVID-19 is or will be a major problem in the future. According to KFF, this is a reversal from perceptions of the pandemic 14 months ago, which was prior to widespread availability of vaccines. In December 2020, one-quarter of the public thought the worst was behind us while half (51%) said the worst is yet to come.

The majority of adults are worried about possible consequences of both lifting and not lifting restrictions. Six in ten are worried about immune-compromised people being left behind due to their increased risk of getting sick (61%), and about half are worried there will be an increased number of deaths in their community or they won’t be able to receive needed medical care because local hospitals could again be overwhelmed when restrictions are relaxed (48%).

The survey goes on to say that nearly half of U.S. adults think it will be safe to resume normal pre-pandemic activities by late spring or sooner, including one-third (35%) who say it safe to do so “now,” 4% in “the next month or so” and one in ten who say it will be safe “by late spring.” Another one in five say they think it will be safe to resume activities by mid-summer (13%) or mid-fall (5%). However, 26% feel it will be at least another year, maybe more, before it will be safe to resume normal pre-pandemic activities.

As for the medical imaging industry, a slow and gradual approach appears to be the norm for now, in large part based on what we are seeing with industry conference patterns. The majority of conferences are offering a hybrid model, where attendees can choose to either attend in person or virtually. The Healthcare Information and Management Systems Society (HIMSS) 2022 annual conference and exhibition held in Orlando in March will be the first event for many since the mandates have been eased. HIMSS is still requiring that attendees and exhibitors show proof of vaccination, and be masked throughout the event. 

The one thing that all survey participants did agree on was that “normal life” is going to look different moving forward. There is no going back to the way things were pre-pandemic, however lessons learned can hopefully help the world move forward as the pandemic starts to morph down to an epidemic.

More HIMSS 2022 content

Related COVID Content:

COVID-19 Fallout May Lead to More Cancer Deaths

Kawasaki-like Inflammatory Disease Affects Children With COVID-19

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

Case Study Describes One of the First U.S. Cases of MIS-C

NIH-funded Project Wants to Identify Children at Risk for MIS-C From COVID-19

Related Content

News | Computed Tomography (CT)

December 2, 2022 — New CT technology outperforms conventional CT in detecting subtle damage in the lungs of patients ...

Time December 02, 2022
News | Coronavirus (COVID-19)

December 1, 2022 — COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver ...

Time December 01, 2022
News | RSNA

November 30, 2022 — Findings from four separate studies on long-term impacts of COVID-19 were presented during a ...

Time November 30, 2022
News | RSNA

November 28, 2022 — Adam E. Flanders, M.D., FSIIM, a prolific mentor, author and pioneer for digital learning, was ...

Time November 28, 2022
News | RSNA | By Christine Book

November 27, 2022 — Among dozens of technical exhibit visits, informative discussions, and captivating Plenary Session ...

Time November 27, 2022
News | RSNA

November 23, 2022 — With the aim of cultivating global partnerships and improving health equity, access, safety and ...

Time November 23, 2022
News | RSNA

Updated November 29, 2022 — The Radiological Society of North America (RSNA) has announced the official results of the ...

Time November 23, 2022
News | Magnetic Resonance Imaging (MRI)

November 21, 2022 — Using a special type of MRI, researchers have uncovered brain changes in patients up to six months ...

Time November 21, 2022
Feature | RSNA | By Alan Stoddart

Top 10 Predictions for RSNA 2022 was published as an infographic as part of Signify Research's Premium Insights service ...

Time November 17, 2022
News | Digital Pathology

November 9, 2022 — GE Healthcare and Tribun Health have entered a collaboration with the intent to provide digital ...

Time November 09, 2022
Subscribe Now